As an expected consequence, in vivo studies in healthy subjects [32] and patients with asthma [32,34] showed that COX-1 inhibition reduced urinary levels of PGD2 metabolites; however, selective COX-2 inhibitors had no inhibitory effects in some [48,49] but not all studies [50]. Here, PTGS2 is linked to asthma.